Clinical Trial: A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436221) titled 'A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma' on Feb. 03.

Brief Summary: This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.

Study Start Date: Feb. 28

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: AK139

AK139 regimen 1- subcutaneous injection.

DRUG: AK139

AK139 regimen 2- subcutaneous injection.

DRUG: AK139

AK139 regimen 3- subcutaneous injection.

DRUG: Placebo

subcutaneous injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Akeso

Disclaimer...